Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 HKD | -13.79% | -3.85% | -54.55% |
Mar. 28 | China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 15 | China NT Pharma Group Company Limited Announces Directorate Changes | CI |
Business Summary
Number of employees: 16
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Proprietary Products
100.0
%
| 273 | 100.0 % | 241 | 100.0 % | -11.86% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 273 | 100.0 % | 241 | 100.0 % | -11.86% |
Managers
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Biao Zhao
BRD | Director/Board Member | 54 | 19-12-30 |
Tit Ng
CEO | Chief Executive Officer | 60 | 94-12-31 |
Yu Chin
FOU | Founder | 60 | 94-12-31 |
Wei Qian
BRD | Director/Board Member | 67 | 10-02-28 |
Tze Shan Yu
BRD | Director/Board Member | 67 | 17-06-28 |
Ming Kwan Ng
BRD | Director/Board Member | 47 | 23-01-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,640,895,000 | 1,246,248,704 ( 47.19 %) | 0 | 47.19 % |
Company contact information
China NT Pharma Group Co., Ltd.
28/F, The Wellington 198 Wellington Street
, Hong Kong
+
http://www.ntpharma.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-54.55% | 8.45M | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- 1011 Stock
- Company China NT Pharma Group Company Limited